glp-1 covered by insurance GLP-1s and The Payer Predicament Why payers are hesitant to
Description
Saudi Arabia Already Happened Heres something that barely got coverage outside of specialist circles: the first approved generic semaglutide in any regulated market globally launched in Saudi Arabia in February 2026
(NASDAQ: ALT)
Eligibility typically depends on income and insurance status
Across multiple trials and medicines
Rakipovski G, Rolin B, Nohr J, Klewe I, Frederiksen KS, Augustin R, et al
Marfella R, Sasso FC, Rizzo MR, et al
